Literature DB >> 29777671

Surgical Management and Outcomes of Ebstein Anomaly in Neonates and Infants: A Society of Thoracic Surgeons Congenital Heart Surgery Database Analysis.

Kimberly A Holst1, Joseph A Dearani2, Sameh M Said1, Ryan R Davies3, Christian Pizarro4, Christopher Knott-Craig5, T K Susheel Kumar5, Vaughn A Starnes6, S Ram Kumar7, Sara K Pasquali8, Dylan P Thibault9, James M Meza10, Kevin D Hill9, Karen Chiswell9, Jeffrey P Jacobs11, Marshall L Jacobs12.   

Abstract

BACKGROUND: Ebstein anomaly (EA) encompasses a broad spectrum of morphology and clinical presentation. Those who are symptomatic early in infancy are generally at highest risk, but there are limited data regarding multicentric practice patterns and outcomes. We analyzed multiinstitutional data concerning operations and outcomes in neonates and infants with EA.
METHODS: Index operations reported in The Society of Thoracic Surgeons Congenital Heart Surgery Database (2010 to 2016) were potentially eligible for inclusion. Analysis was limited to patients with diagnosis of EA and less than 1 year of age at time of surgery (neonates ≤30 days, infants 31 to 365 days).
RESULTS: The study population included 255 neonates and 239 infants (at 95 centers). Among neonates, median age at operation was 7 days (interquartile range, 4 to 13 days) and the majority required preoperative ventilation (61.6%, n = 157). The most common primary operation performed among neonates was Ebstein repair (39.6%, n = 101), followed by systemic-to-pulmonary shunt (20.4%, n = 52) and tricuspid valve closure (9.4%, n = 24). Overall neonatal operative mortality was 27.4% (n = 70), with composite morbidity-mortality of 51.4% (n = 48). For infants, median age at operation was 179 days (interquartile range, 108-234 days); the most common primary operation for infants was superior cavopulmonary anastomosis (38.1%, n = 91) followed by Ebstein repair (15.5%, n = 37). Overall operative mortality for infants was 9.2% (n = 22) with composite morbidity-mortality of 20.1% (48).
CONCLUSIONS: Symptomatic EA in early infancy is very high risk and a variety of operative procedures were performed. A dedicated prospective study is required to more fully understand optimal selection of treatment pathways to guide a systematic approach to operative management.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29777671     DOI: 10.1016/j.athoracsur.2018.04.049

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Mid-term outcomes of individualized surgeries in patients with Ebstein's anomaly.

Authors:  Jiaquan Zhu; Li Zhang; Chunrong Bao; Fangjie Xu; Fangbao Ding; Ju Mei
Journal:  Heart Vessels       Date:  2019-03-08       Impact factor: 2.037

Review 2.  The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2019 Update on Research.

Authors:  Marshall L Jacobs; Jeffrey P Jacobs; Kevin D Hill; Sean M O'Brien; Sara K Pasquali; David Vener; S Ram Kumar; Karen Chiswell; James D St Louis; John E Mayer; Robert H Habib; David M Shahian; Felix G Fernandez
Journal:  Ann Thorac Surg       Date:  2019-07-20       Impact factor: 4.330

Review 3.  Ebstein's anomaly in the neonate.

Authors:  T K Susheel Kumar
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-03-21

4.  Surgical management of Ebstein anomaly: impact of the adult congenital heart disease anatomical and physiological classifications.

Authors:  Laura Homzova; Joachim Photiadis; Nicodème Sinzobahamvya; Stanislav Ovroutski; Mi-Young Cho; Antonia Schulz
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19

5.  Early and Long-Term Outcomes of Surgical Treatment of Ebstein's Anomaly.

Authors:  Guilherme Viotto Rodrigues da Silva; Leonardo Augusto Miana; Luiz Fernando Caneo; Aída Luiza Ribeiro Turquetto; Carla Tanamati; Juliano G Penha; Fabio B Jatene; Marcelo B Jatene
Journal:  Braz J Cardiovasc Surg       Date:  2019-12-01

6.  Risk Factors for Mortality and Circulatory Outcome Among Neonates Prenatally Diagnosed With Ebstein Anomaly or Tricuspid Valve Dysplasia: A Multicenter Study.

Authors:  Lindsay R Freud; Doff B McElhinney; Brian T Kalish; Maria C Escobar-Diaz; Rukmini Komarlu; Michael D Puchalski; Edgar T Jaeggi; Anita L Szwast; Grace Freire; Stéphanie M Levasseur; Ann Kavanaugh-McHugh; Erik C Michelfelder; Anita J Moon-Grady; Mary T Donofrio; Lisa W Howley; Elif Seda Selamet Tierney; Bettina F Cuneo; Shaine A Morris; Jay D Pruetz; Mary E van der Velde; John P Kovalchin; Catherine M Ikemba; Margaret M Vernon; Cyrus Samai; Gary M Satou; Nina L Gotteiner; Colin K Phoon; Norman H Silverman; Wayne Tworetzky
Journal:  J Am Heart Assoc       Date:  2020-10-20       Impact factor: 5.501

7.  Early Outcomes of the Norwood Procedure in a Reference Center in Brazil.

Authors:  Rodrigo Freire Bezerra; Juliana Torres Pacheco; Sônia Meiken Franchi; Rosangela Belbuche Fittaroni; José Francisco Baumgratz; Rodrigo Moreira Castro; Luciana da Fonseca da Silva; José Pedro da Silva
Journal:  Arq Bras Cardiol       Date:  2022-08       Impact factor: 2.667

8.  Outcomes and risk analysis after tricuspid valve surgery for non-Ebstein 2-ventricle congenital tricuspid valve diseases.

Authors:  David Blitzer; Ismail Bouhout; Eliana Al Haddad; Matthew Lewis; Kanwal Farooqi; Amee Shah; Noa Zemer-Wassercug; Harsimran Singh; Brett Anderson; Emile Bacha; David Kalfa
Journal:  JTCVS Open       Date:  2022-07-05

Review 9.  Surgical outcomes in complex adult congenital heart disease: a brief review.

Authors:  Alice Chan; Amna Aijaz; Ali N Zaidi
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

10.  Commentary: Never let the truth get in the way of a good story.

Authors:  Bahaaldin Alsoufi
Journal:  JTCVS Tech       Date:  2020-06-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.